IRIS
USIELLO, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.801
NA - Nord America 3.640
AS - Asia 3.114
SA - Sud America 545
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 15.144
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 5.132
US - Stati Uniti d'America 3.579
SG - Singapore 1.200
IE - Irlanda 894
CN - Cina 611
HK - Hong Kong 471
BR - Brasile 458
UA - Ucraina 383
VN - Vietnam 368
IT - Italia 348
GB - Regno Unito 323
DE - Germania 240
TR - Turchia 114
FI - Finlandia 111
SE - Svezia 110
KR - Corea 92
IN - India 80
GR - Grecia 72
NL - Olanda 58
JP - Giappone 50
FR - Francia 46
AR - Argentina 35
AT - Austria 30
BD - Bangladesh 25
MX - Messico 25
CA - Canada 24
IQ - Iraq 18
ID - Indonesia 17
ZA - Sudafrica 14
BE - Belgio 13
EC - Ecuador 12
PK - Pakistan 12
UZ - Uzbekistan 11
CL - Cile 9
VE - Venezuela 9
CO - Colombia 8
ES - Italia 8
PL - Polonia 7
MA - Marocco 6
KE - Kenya 5
PE - Perù 5
PY - Paraguay 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
JO - Giordania 4
LT - Lituania 4
NP - Nepal 4
TN - Tunisia 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
BH - Bahrain 3
EU - Europa 3
HN - Honduras 3
KG - Kirghizistan 3
PT - Portogallo 3
TH - Thailandia 3
AL - Albania 2
AU - Australia 2
BB - Barbados 2
CH - Svizzera 2
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
NG - Nigeria 2
PH - Filippine 2
PR - Porto Rico 2
RO - Romania 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
NA - Namibia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 15.144
Salva come PNG Salva come JPEG
Città #
Moscow 1.830
Dublin 888
Jacksonville 587
Santa Clara 532
Singapore 521
Hong Kong 466
Chandler 360
San Jose 260
Ho Chi Minh City 143
Ashburn 136
Princeton 123
Medford 105
Hefei 104
Hanoi 83
Seoul 82
Roxbury 80
Boardman 74
Ann Arbor 73
Beijing 70
San Mateo 60
Wilmington 57
Bengaluru 52
Cambridge 49
São Paulo 47
Woodbridge 46
New York 45
The Dalles 44
Houston 40
Mountain View 37
Dallas 29
Zhengzhou 29
Naples 27
Napoli 26
Caserta 24
Des Moines 22
Los Angeles 21
Da Nang 19
Norwalk 18
Haiphong 17
Nanjing 17
Nuremberg 17
Rio de Janeiro 17
Santa Maria Capua Vetere 17
Aversa 16
Salerno 15
Vienna 15
Council Bluffs 14
Düsseldorf 14
Hải Dương 14
Brasília 13
Bremen 13
Brussels 13
Porto Alegre 11
Tashkent 11
Frankfurt am Main 10
Helsinki 10
Milan 10
Munich 10
Paris 10
Auburn Hills 9
Baghdad 9
Biên Hòa 9
Kunming 9
London 9
Viterbo 9
Chennai 8
Jinan 8
Shanghai 8
Belo Horizonte 7
Brooklyn 7
Campinas 7
Chicago 7
Curitiba 7
Dearborn 7
Mexico City 7
Montreal 7
Orem 7
Ribeirão Preto 7
San Francisco 7
Sorrento 7
Tappahannock 7
Tianjin 7
Tokyo 7
Venice 7
Cava 6
Dhaka 6
Grafing 6
Piscataway 6
Rimini 6
Salvador 6
Turku 6
Warsaw 6
Xiamen 6
Amorosi 5
Boston 5
Hangzhou 5
Johannesburg 5
Juiz de Fora 5
Lanzhou 5
Lappeenranta 5
Totale 7.772
Salva come PNG Salva come JPEG
Nome #
D-Aspartate drinking solution alleviates pain and cognitive impairment in neuropathic mice. 226
Quantitative determination of free D-Asp, LAsp and N-methyl-D-aspartate in mouse brain tissues by chiral separation and Multiple Reaction Monitoring tandem mass spectrometry 192
Age-Related Changes in D-Aspartate Oxidase Promoter Methylation Control Extracellular D-Aspartate Levels and Prevent Precocious Cell Death during Brain Aging 188
D-aspartate modulates nociceptive-specific neuron activity and pain threshold in inflammatory and neuropathic pain condition in mice 180
Caffeine as a psychomotor stimulant: mechanism of action 177
AMPA receptor expression in mouse testis and spermatogonial GC-1 cells: A study on its regulation by excitatory amino acids 176
Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice 174
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice 173
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients 166
N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes 163
Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity. 163
Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain 151
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis 148
N-methyl-D-aspartate receptors in the nucleus accumbens are involved in detection of spatial novelty in mice 148
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 147
D-aspartate oxidase gene duplication induces social recognition memory deficit in mice and intellectual disabilities in humans 146
Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice 146
Bimodal effect of D-aspartate on brain aging processes: insights from animal models. 145
The A1 adenosine receptor as a new player in microglia physiology 143
D-aspartate depletion perturbs steroidogenesis and spermatogenesis in mice 140
d-Aspartate: An endogenous NMDA receptor agonist enriched in the developing brain with potential involvement in schizophrenia 140
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 137
Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and 'Schizophrenia-Like Behaviors' in Mice. 132
d-Aspartate activates mGlu receptors coupled to polyphosphoinositide hydrolysis in neonate rat brain slices 132
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes 132
Adaptations of striatal endocannabinoid system during stress 130
The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons 130
Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward 129
Distinct Functions of the two isoforms of dopamine D2 receptors 129
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post‐Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients 129
Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine 128
Abnormal RasGRP1 Expression in the Post-Mortem Brain and Blood Serum of Schizophrenia Patients 127
Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein Kinase A site in striatal projection neurons 126
Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D2 dopamine receptor 126
Dysfunctional dopaminergic neurotransmission in asocial BTBR mice. 126
Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects 125
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum 124
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 123
A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice. 122
Association of GSK-3 beta Genetic Variation With GSK-3 beta Expression, Prefrontal Cortical Thickness, Prefrontal Physiology, and Schizophrenia 122
d-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain 121
Decreased free d -aspartate levels are linked to enhanced d -aspartate oxidase activity in the dorsolateral prefrontal cortex of schizophrenia patients 121
D-aspartate dysregulation in Ddo(-/-) mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum. 120
D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801. 118
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 118
Reversal of Metabolic and Neurological Symptoms of Phenylketonuric Mice Treated with a PAH Containing Helper-Dependent Adenoviral Vector 117
New evidence on the role of d‐aspartate metabolism in regulating brain and endocrine system physiology: From preclinical observations to clinical applications 116
Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy 115
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis. 115
Increased d-aspartate brain content rescues hippocampal age-related synaptic plasticity deterioration of mice 115
Cerebrospinal fluid and serum d-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer's disease. 115
Voluntary Exercise and Sucrose Consumption Enhance Cannabinoid CB1 Receptor Sensitivity in the Striatum 114
Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: Role of endogenous acetylcholine 114
Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia. 114
Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia 113
Changes in extracellular dopamine induced by morphine and cocaine: Crucial control by D2 receptors 113
Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. 113
Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons. 112
Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and post synaptic sites 111
Nusinersen Induces Disease-Severity-Specific Neurometabolic Effects in Spinal Muscular Atrophy 110
Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals. 110
Motor training compensates for cerebellar dysfunctions caused by oligodendrocytes ablation 110
Preservation of striatal cannabinoid CB1 receptor function correlates with the anti-anxiety effects of FAAH inhibition 109
The γ-Secretase Modulator CHF5074 Restores Memory and Hippocampal Synaptic Plasticity in Plaque-Free Tg2576 Mice 109
Histone H3 Phosphorylation is Under the Opposite Tonic Control of Dopamine D2 and Adenosine A2A Receptors in Striatopallidal Neurons 109
D-Aspartate: an atypical amino acid with neuromodulatory activity in mammals 108
DARPP-32 and modulation of cAMP signaling: involvement in motor control and levodopa-induced dyskinesia 108
Modeling DNA methylation by analyzing the individual configurations of single molecules. 108
Loss of striatal cannabinoid CB1 receptor function in attention-deficit/hyperactivity disorder mice with point-mutation of the dopamine transporter 107
Dysfunctional d-aspartate metabolism in BTBR mouse model of idiopathic autism. 107
Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion. 106
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons 106
Free D-aspartate triggers NMDA receptor-dependent cell death in primary cortical neurons and perturbs JNK activation, Tau phosphorylation, and protein SUMOylation in the cerebral cortex of mice lacking D-aspartate oxidase activity 106
Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats 105
DNA methylation state of BDNF gene is not altered in prefrontal cortex and striatum of schizophrenia subjects. 104
Dopamine D2 Receptor-Mediated Inhibition of Dopaminergic Neurons in Mice Lacking D2L Receptors 104
The activity of the Spinal Muscular Atrophy protein is regulated during development and cellular differentiation 104
Decreased free D-aspartate levels in the blood serum of patients with schizophrenia 103
Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia 103
Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias 103
High performance liquid chromatography determination of l-glutamate, l-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer’s disease 102
Thyroid hormones and D-aspartic acid, D-aspartate oxidase, D-aspartate racemase, H2O2, and ROS in rats and mice 101
Tracking the evolution of epialleles during neural differentiation and brain development: D-Aspartate oxidase as a model gene 101
Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease 100
Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine 100
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors 100
Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility 100
Pharmacological validation of a mouse model of Parkinson’s disease and L-DOPA-induced dyskinesia 100
Higher free d-aspartate and N-methyl-d-aspartate levels prevent striatal depotentiation and anticipate l-DOPA-induced dyskinesia 100
Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons. 100
Otx2 regulates the extent, identity and fate of neuronal progenitor domains in the ventral midbrain 99
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System. 99
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 99
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 98
Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol 98
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 98
Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and UBC9 97
Neonatal 192 IgG-saporin lesions of basal forebrain cholinergic neurons selectively impair response to spatial novelty in adult rats 97
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms. 96
Correction of reference memory and synaptic plasticity impairments of pku mice after a single injection of a helper-dependent adenoviral vector expressing pah 95
Totale 12.275
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.361
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021227 0 0 0 0 0 0 0 0 0 113 95 19
2021/2022734 66 3 3 11 247 6 8 24 24 44 56 242
2022/20231.564 137 8 24 130 132 114 1 81 844 19 33 41
2023/2024547 52 17 15 50 198 37 29 17 2 3 28 99
2024/20252.066 3 5 12 41 319 309 233 167 286 398 173 120
2025/20268.155 219 362 436 421 674 4.800 453 247 372 171 0 0
Totale 15.514